Literature DB >> 27897381

Pathologic fracture in childhood and adolescent osteosarcoma: A single-institution experience.

Lindsay Haynes1, Sue C Kaste2,3, Kirsten K Ness4, Jianrong Wu5, Lucia Ortega-Laureano1, Michael Bishop6, Michael Neel1, Bhaskar Rao1, Israel Fernandez-Pineda1.   

Abstract

PURPOSE: Pathologic fractures occur in 5-10% of pediatric osteosarcoma (OS) cases and have historically been considered a contraindication to limb salvage. Our purpose was to describe the radiographic features of pathologic fracture and examine its impact on local recurrence rates, functional outcomes, and overall survival.
METHODS: We retrospectively analyzed patients at our institution from 1990 to 2015 with pathologic fracture at diagnosis or during neoadjuvant chemotherapy. We selected a control group of 50 OS patients of similar age and gender without pathologic fracture from 1990 to 2015. Functional outcomes were scored using Musculoskeletal Tumor Society criteria. Chi-square test was used for comparative analysis of groups.
RESULTS: Thirty-six patients with 37 pathologic fractures form the study cohort. Of patients who received surgery, 18 of 34 patients with fracture underwent amputation compared to 8 of 48 patients in the nonfracture group (P = 0.007). Indications for amputation in fracture patients were tumor size (n = 7), neurovascular involvement (n = 6), and tumor progression during neoadjuvant chemotherapy (n = 5). Only one patient (2.9%) in the fracture group who underwent limb salvage suffered local recurrence. Of patients who received neoadjuvant chemotherapy, 25 of 34 fracture patients showed poor histological response compared to 24 of 47 nonfracture patients (P = 0.044). There was no statistically significant difference in overall survival (P = 0.96). Functional outcomes were significantly lower in fracture patients (median = 17.5) than nonfracture patients (median = 24) (P = 0.023).
CONCLUSIONS: Radiographic features of pathologic fractures were highly variable in this population. Limb salvage surgery can be performed without increased risk of local recurrence. Patients with pathologic fracture suffer worse functional outcomes but no decrease in overall survival.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  functional outcomes; pathologic fracture; pediatric osteosarcoma

Mesh:

Year:  2016        PMID: 27897381      PMCID: PMC5319893          DOI: 10.1002/pbc.26290

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  27 in total

1.  Protocol of surgical treatment of long bone pathological fractures.

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Roberto Casadei; Costantino Errani; Andrea Angelini; Teresa Calabrò; Elisa Pala; Mario Mercuri
Journal:  Injury       Date:  2010-10-14       Impact factor: 2.586

2.  Limb salvage surgery for pathological fractures in osteosarcoma.

Authors:  M V Natarajan; R H Govardhan; S Williams; T S Raja Gopal
Journal:  Int Orthop       Date:  2000       Impact factor: 3.075

3.  Frontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trial.

Authors:  Najat C Daw; Michael D Neel; Bhaskar N Rao; Catherine A Billups; Jianrong Wu; Jesse J Jenkins; Juan Quintana; Lori Luchtman-Jones; Milena Villarroel; Victor M Santana
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

4.  Prognostic effect of pathologic fracture in localized osteosarcoma: a cohort/case controlled study at a single institute.

Authors:  Min S Kim; Soo-Yong Lee; Tae R Lee; Wan H Cho; Won S Song; Sang H Cho; Jun A Lee; Ji Y Yoo; Sung T Jung; Dae-Geun Jeon
Journal:  J Surg Oncol       Date:  2009-09-01       Impact factor: 3.454

5.  Pathological fracture as the presenting feature in pediatric osteosarcoma.

Authors:  Ryan K L Lee; Winnie C W Chu; Joyce H Y Leung; Frankie W T Cheng; C K Li
Journal:  Pediatr Blood Cancer       Date:  2012-12-31       Impact factor: 3.167

6.  Do pathological fractures influence survival and local recurrence rate in bony sarcomas?

Authors:  J A M Bramer; A A Abudu; R J Grimer; S R Carter; R M Tillman
Journal:  Eur J Cancer       Date:  2007-08-14       Impact factor: 9.162

7.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

8.  Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.

Authors:  Gaetano Bacci; Stefano Ferrari; Alessandra Longhi; Davide Donati; Marco Manfrini; Stefano Giacomini; Antonio Briccoli; Cristiana Forni; Stefano Galletti
Journal:  Acta Orthop Scand       Date:  2003-08

9.  Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.

Authors:  Dongqing Zuo; Longpo Zheng; Wei Sun; Yingqi Hua; Zhengdong Cai
Journal:  World J Surg Oncol       Date:  2013-06-24       Impact factor: 2.754

10.  Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI.

Authors:  J Guo; J O Glass; M B McCarville; B L Shulkin; V M Daryani; C F Stewart; J Wu; S Mao; J R Dwek; L M Fayad; J E Madewell; F Navid; N C Daw; W E Reddick
Journal:  Br J Cancer       Date:  2015-10-13       Impact factor: 7.640

View more
  4 in total

1.  Meta-analysis of the prognosis after surgical treatment of osteosarcoma complicated by pathologic fracture.

Authors:  Wei Zhong; Ziyi Wu; Yuhao Yuan; Wei Luo
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

Review 2.  Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas.

Authors:  Farinaz Barghi; Harlan E Shannon; M Reza Saadatzadeh; Barbara J Bailey; Niknam Riyahi; Khadijeh Bijangi-Vishehsaraei; Marissa Just; Michael J Ferguson; Pankita H Pandya; Karen E Pollok
Journal:  Cancers (Basel)       Date:  2022-07-25       Impact factor: 6.575

Review 3.  Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.

Authors:  Juanjuan Han; Hui Kong; Xueqiang Wang; Xin-An Zhang
Journal:  Cell Prolif       Date:  2022-06-23       Impact factor: 8.755

4.  Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.

Authors:  Santiago A Lozano Calderón; Cassandra Garbutt; Jason Kim; Christopher E Lietz; Yen-Lin Chen; Karen Bernstein; Ivan Chebib; G Petur Nielsen; Vikram Deshpande; Renee Rubio; Yaoyu E Wang; John Quackenbush; Thomas Delaney; Kevin Raskin; Joseph Schwab; Gregory Cote; Dimitrios Spentzos
Journal:  Clin Orthop Relat Res       Date:  2019-09       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.